ClassID:

109348

C12N2501/2333 - CPC Classification

Classification description:

Active agents used in cell culture processes, e.g. differentation; Cytokines; Chemokines; Interleukins [IL] Interleukin-33 (IL-33)

Recent Application in this class:
#1
20260109949
2026-04-23

T CELL PRODUCTION METHOD

#2
20230242878
2023-08-03

EXPANSION OF GAMMA DELTA T CELLS, COMPOSITIONS, AND METHODS OF USE THEREOF

#3
20230226119
2023-07-20

UMBILICAL CORD DERIVED REGENERATIVE AND IMMUNE MODULATORY STEM CELL POPULATIONS

#4
20220226440
2022-07-21

MODULATION OF CANCER IMMUNITY WITH TYPE 2 INNATE LYMPHOID CELLS, INTERLEUKIN 33, AND/OR INTERFERON INDUCED PROTEIN 44

#5
20220031741
2022-02-03

Methods and reagents for modulating macrophage phenotype

#6
20210177895
2021-06-17

METHODS OF MODULATING M2 MACROPHAGE POLARIZATION AND USE OF SAME IN THERAPY

#7
20210147800
2021-05-20

METHODS FOR PRODUCING REGULATORY IMMUNE CELLS AND USES THEREOF

#8
20210087528
2021-03-25

Expansion of γδ T cells, compositions, and methods of use thereof

#9
20200155656
2020-05-21

Compositions and methods for preventing and treating graft versus host disease

#10
20190290688
2019-09-26

Methods and reagents for modulating macrophage phenotype

#11
20190125800
2019-05-02

TYPE 2 INNATE LYMPHOID CELLS AND METHODS OF ENRICHING AND GROWING

#12
20180139937
2018-05-24

CELL CULTURE SYSTEMS FOR PRODUCING IL-33 INDUCED T9 CELLS AND METHODS OF USING THE CELLS

#13
20180125887
2018-05-10

ANTI-INFLAMMATORY AGENTS

#14
20180050091
2018-02-22

Modulation of cancer immunity with type 2 innate lymphoid cells, interleukin 33, and/or interferon induced protein 44

#15
20170360907
2017-12-21

COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING GRAFT VERSUS HOST DISEASE

#16
20170196951
2017-07-13

POLYVALENT ANTI-TUMOR FIBROBLAST VACCINE

#17
20150306139
2015-10-29

ANTI-INFLAMMATORY AGENTS

#18
20150259645
2015-09-17

METHOD FOR INDUCING IL-2-FREE PROLIFERATION OF GAMMA DELTA T CELLS